Simulations Plus, Inc. (SLP) bolstered its flagship quantitative systems toxicology (QST) platform with the launch of DILIsym 11. This new release advances drug-induced liver injury (DILI) prediction, with cutting-edge features like pediatric representation and an enhanced T-cell model, solidifying Simulations Plus’s commitment to improving drug safety and patient outcomes.DILIsym 11 introduces several powerful enhancements to extend its predictive reach and improve simulation accuracy. The enhanced version ...

Schrödinger (SDGR) 2025 Conference May 14, 2025 04:40 PM ET Speaker0 My name is Mike Riskin. I'm on the life science tools and diagnostics team here at Bank of America, and we're excited to be joined by the Schrodinger team. Thanks so much for coming. I think we're gonna kick things off with a quick presentation, and then we'll go into a fireside chat and q and Okay. Speaker1 Thanks, Mike. I'm Jeff Borges, the CFO of Schrodinger, and I will give you a quick overview of the company, and then we'll get into a ...